ATARA BIOTHERAPEUTICS

atara-biotherapeutics-logo

Atara Biotherapeutics, Inc. (@Atarabio) is an off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases. Ataraโ€™s technology platform leverages research collaborations with leading academic institutions with the Companyโ€™s scientific, clinical, regulatory, and manufacturing expertise. Ataraโ€™s pipeline includes tab-celยฎ (tabelecleucel), which is in Phase 3 development for patients with Epstein-Barr virus-associ... ated post-transplant lymphoproliferative disorder (EBV+ PTLD) as well as in earlier stage development for other EBV-associated hematologic malignancies and solid tumors, including nasopharyngeal carcinoma (NPC); T-cell immunotherapies targeting EBV antigens believed to be important for the potential treatment of multiple sclerosis; and next-generation chimeric antigen receptor T-cell (CAR T) immunotherapies. The company was founded in 2012 and is co-located in South San Francisco and Southern California. Our Southern California hub is anchored by the state-of-the-art Atara T-cell Operations and Manufacturing (ATOM) facility in Thousand Oaks, California. For additional information about the company, please visit atarabio.com.

#People #Financial #Event #Website #More

ATARA BIOTHERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Founded:
2012-01-01

Address:
South San Francisco, California, United States

Country:
United States

Website Url:
http://www.atarabio.com

Total Employee:
251+

Status:
Active

Contact:
+1 650 278 8930

Email Addresses:
[email protected]

Total Funding:
59.32 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network



Current Advisors List

beth-seidenberg_image

Beth Seidenberg Member of the Board of Directors @ Atara Biotherapeutics
Board_member

ameet-mallik_image

Ameet Mallik Board Member @ Atara Biotherapeutics
Board_member
2021-08-01

matthew-fust_image

Matthew Fust Audit Committee Chair @ Atara Biotherapeutics
Board_member

carol-gallagher_image

Carol Gallagher Executive Chair @ Atara Biotherapeutics
Board_member

Current Employees Featured

charlene-banard_image

Charlene Banard
Charlene Banard CTO @ Atara Biotherapeutics
CTO
2022-04-01

jill-henrich_image

Jill Henrich
Jill Henrich SVP, Global Regulatory Affairs @ Atara Biotherapeutics
SVP, Global Regulatory Affairs
2020-09-01

aj-joshi_image

AJ Joshi
AJ Joshi Chief Medical Officer @ Atara Biotherapeutics
Chief Medical Officer

tim-valko_image

Tim Valko
Tim Valko Head of Global Manufacturing and Supply Chain @ Atara Biotherapeutics
Head of Global Manufacturing and Supply Chain

utpal-koppikar_image

Utpal Koppikar
Utpal Koppikar Chief Financial Officer & Senior Vice President @ Atara Biotherapeutics
Chief Financial Officer & Senior Vice President

kristin-yarema_image

Kristin Yarema
Kristin Yarema Chief Commercial Officer @ Atara Biotherapeutics
Chief Commercial Officer

christiane-langer_image

Christiane Langer
Christiane Langer Head of Global Medical Affairs @ Atara Biotherapeutics
Head of Global Medical Affairs

christopher-haqq_image

Christopher Haqq
Christopher Haqq Executive Vice President of Research & Development & Chief Scientific Officer @ Atara Biotherapeutics
Executive Vice President of Research & Development & Chief Scientific Officer
2016-10-01

joe-newell_image

Joe Newell
Joe Newell Chief Operations Officer @ Atara Biotherapeutics
Chief Operations Officer

steve-bertram_image

Steve Bertram
Steve Bertram SVP, Chief People Officer @ Atara Biotherapeutics
SVP, Chief People Officer

Founder


isaac-ciechanover_image

Isaac Ciechanover

Stock Details


Company's stock symbol is NASDAQ:ATRA

Investors List

4bio-capital-partners_image

4BIO Capital

4BIO Capital investment in Post-IPO Equity - Atara Biotherapeutics

domain-associates_image

Domain Associates

Domain Associates investment in Series B - Atara Biotherapeutics

dag-ventures_image

DAG Ventures

DAG Ventures investment in Series B - Atara Biotherapeutics

celgene_image

Celgene

Celgene investment in Series B - Atara Biotherapeutics

alexandria-venture_image

Alexandria Venture

Alexandria Venture investment in Series B - Atara Biotherapeutics

kleiner-perkins-caufield-byers_image

Kleiner Perkins

Kleiner Perkins investment in Series B - Atara Biotherapeutics

ecor1-capital_image

EcoR1 Capital

EcoR1 Capital investment in Series B - Atara Biotherapeutics

amgen-ventures_image

Amgen Ventures

Amgen Ventures investment in Series B - Atara Biotherapeutics

domain-associates_image

Domain Associates

Domain Associates investment in Series B - Atara Biotherapeutics

kleiner-perkins-caufield-byers_image

Kleiner Perkins

Kleiner Perkins investment in Series B - Atara Biotherapeutics

Official Site Inspections

http://www.atarabio.com Semrush global rank: 2.19 M Semrush visits lastest month: 9.02 K

  • Host name: 141.193.213.11
  • IP address: 141.193.213.11
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Atara Biotherapeutics" on Search Engine